Joseph Armellino

Title: Joseph Armellino: Innovator in Migraine Treatment

Introduction

Joseph Armellino is a notable inventor based in Chester, NJ (US). He has made significant contributions to the field of medicine, particularly in the treatment of migraine pain. His innovative approach combines well-known medications to provide relief for those suffering from migraines.

Latest Patents

Joseph Armellino holds a patent for a composition that includes a nonprescription combination of acetaminophen, aspirin, and caffeine (APAP/ASA/CAF). This invention offers a safe and economical solution for treating migraine pain and alleviating associated symptoms such as nausea, photophobia, phonophobia, and functional disabilities. The APAP/ASA/CAF combination is also effective in aborting the prodrome phase of a migraine attack.

Career Highlights

Armellino is associated with Bristol-Myers Squibb Company, a leading global biopharmaceutical company. His work there has allowed him to focus on developing effective treatments for various health conditions, including migraines. His dedication to innovation in this field has made a positive impact on many patients.

Collaborations

Joseph Armellino collaborates with Randy J. Koslo, a coworker who shares his commitment to advancing medical treatments. Their partnership exemplifies the importance of teamwork in the pursuit of innovative solutions.

Conclusion

Joseph Armellino's contributions to migraine treatment through his patented invention highlight his role as an important figure in the field of medicine. His work continues to benefit those who suffer from migraines, showcasing the impact of innovation in healthcare.